IP Library Granted Patent US 7,670,810
Granted Patent B2
US 7,670,810 · App. 10/872,141 · Granted Mar 2, 2010

Methods and compositions for whole genome amplification and genotyping

Assignee: Illumina, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,670,810
App. No.
10/872,141
Granted
Mar 2, 2010
Kind
B2
Abstract

This invention provides methods of amplifying genomic DNA to obtain an amplified representative population of genome fragments. Methods are further provided for obtaining amplified genomic DNA representations of a desired complexity. The invention further provides methods for simultaneously detecting large numbers of typable loci for an amplified representative population of genome fragments. Accordingly the methods can be used to genotype individuals on a genome-wide scale.

Claims (37)

1. A method for detecting at least 10,000 typable loci comprising single-nucleotide polymorphisms (SNPs) of genome fragments, comprising:

(a) providing a plurality of genome fragments of a whole genome,

wherein said providing comprises representationally amplifying a whole, native genome, and

wherein said plurality of genome fragments comprises a concentration of at least 1 μg/μl of DNA;

(b) contacting said plurality of genome fragments with an array of at least 10,000 predetermined nucleic acid probes immobilized to a substrate,

wherein said probes comprise a region of at most 100 nucleotides in length that is complementary to typable loci of a genome, and

wherein said probes hybridize with genome fragments to form probe-fragment hybrids;

(c) modifying the probe of a probe-fragment hybrid while hybridized to said genome fragments by adding a detectable nucleotide or nucleotide analog by a polymerase;

(d) exposing said modified probes to denaturing conditions, thereby removing hybridized genome fragments; and

(e) detecting said modified probes, thereby detecting at least 10,000 typable loci comprising SNPs.

2. The method of claim 1 , wherein said providing comprises linker adapter-PCR.

3. The method of claim 1 , wherein said providing comprises random primer amplification.

4. The method of claim 1 , comprising amplification using a polymerase having low processivity.

5. The method of claim 1 , wherein said native genome that is representationally amplified comprises concatenated DNA produced by ligating fragmented genomic DNA.

6. The method of claim 1 , wherein the addition by a polymerase is a single-base extension (SBE).

7. The method of claim 1 , wherein said denaturing conditions comprises chemical denaturation.

8. The method of claim 1 , wherein said denaturing conditions comprises heat denaturation.

9. The method of claim 1 , further comprising a step of denaturing said native genome prior to step (a).

10. The method of claim 9 , wherein said denaturing comprises heat denaturing.

11. The method of claim 1 , wherein the addition by a polymerase is an allele-specific primer extension (ASPE).

12. The method of claim 1 , 3 , 6 , or 11 , wherein at least 500,000 of said different nucleic acid probes hybridize with genome fragments to form probe-fragment hybrids.

13. The method of claim 12 , wherein said different nucleic acid probes are attached to particles.

14. The method of claim 12 , wherein step (a) is carried out in a capillary gap flow cell.

15. The method of claim 12 , wherein said probes are at most 50 nucleotides in length.

16. The method of claim 12 , wherein said modified probe-comprises a detection moiety.

17. The method of claim 1 , 3 , 2 , 5 , 6 or 11 , wherein genome fragments in said plurality of genome fragments are at most 0.6 kb in length.

18. The method of claim 1 , 3 , 2 , 5 , 6 or 11 , wherein said plurality of genome fragments comprises at least 100 μg of DNA.

19. The method of claim 3 , 5 , 6 or 11 , wherein said amplification is performed isothermally.

20. The method of claim 1 , 3 , 2 , 5 , 6 or 11 , wherein said amplified population is amplified at least 10-fold.

21. The method of claim 1 , 3 , 2 , 5 , 6 or 11 , wherein a complexity of at least 1 Gigabase of unique sequence of said genome is present in said plurality of genome fragments.

22. The method of claim 21 , wherein a complexity of at least 2 Gigabases of unique sequence of said genome is present in said plurality of genome fragments.

23. The method of claim 1 , 6 , or 11 , further comprising the step of

(b1) after step (a), contacting the plurality of nucleic acid probes with an ectopic extension inhibitor (EEI) under conditions wherein probe-ELI hybrids are formed;

whereby step (c) detects probe-fragment hybrids selectively compared to probe-EEI hybrids.

24. The method of claim 23 , wherein the ELI is a single-stranded nucleic acid binding protein.

25. The method of claim 23 , wherein the EEI is a blocking oligonucleotide that is complementary to the 3′-end of a nucleic acid probe.

26. The method of claim 23 , wherein the first and second regions of the nucleic acid probe do not substantially anneal at temperatures used during probe-fragment hybridization, but anneal to form hairpin structures at temperatures used during polymerase addition.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2004
From: GUNDERSON, KEVIN; STEEMERS, FRANK
To: ILLUMINA, INC.
Reel/Frame 016001/0781 →
Continuity (3)
Continuation In Part 1068180000 · Oct 8, 2003
Continuation 1060063400 · Jun 20, 2003
Related Publication 20050059048A1 · Mar 17, 2005